Insider · CIK 0001924188

Salas Eduardo Rene

Reports to the SEC for 2 companies · RAMSEY, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001924188

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-09	ADMAADMA BIOLOGICS, INC.A Award	Director	AAward	+10.7K sh	—	—	21,579
2026-02-09	ADMAADMA BIOLOGICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+17.7K sh	—	—	17,730
2025-04-02	Intra-Cellular Therapies, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−1,567 sh	$132.00	−$207K	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.8K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,009 sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,322 sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−2,951 sh	—	—	0
2025-02-19	ADMAADMA BIOLOGICS, INC.A Award	Director	AAward	+10.9K sh	—	—	10,889
2025-02-19	ADMAADMA BIOLOGICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+16.3K sh	—	—	16,279
2024-12-30	ADMAADMA BIOLOGICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,011
2024-06-23	Intra-Cellular Therapies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,567 sh	—	—	1,567
2024-06-23	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,567 sh	—	—	0
2024-06-14	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	Director	AAward	+2,951 sh	—	—	2,951
2024-06-14	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	Director	AAward	+4,322 sh	—	—	4,322
2023-06-23	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	Director	AAward	+1,567 sh	—	—	1,567
2023-06-23	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	Director	AAward	+7,009 sh	—	—	7,009
2022-06-09	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	Director	AAward	+16.8K sh	—	—	16,757
2022-04-20	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000

Recent filings

Accepted (ET)
Feb 114
Salas Eduardo Rene0001140361-26-004887
SEC(opens sec.gov)
Apr 24
Salas Eduardo Rene0000950170-25-049830
SEC(opens sec.gov)
Feb 214
Salas Eduardo Rene0001140361-25-005539
SEC(opens sec.gov)
Jan 24
Salas Eduardo Rene0001140361-25-000079
SEC(opens sec.gov)
Jun 254
Salas Eduardo Rene0000950170-24-077470
SEC(opens sec.gov)
Jun 184
Salas Eduardo Rene0000950170-24-075082
SEC(opens sec.gov)
Jun 274
Salas Eduardo Rene0001209191-23-039929
SEC(opens sec.gov)
Jun 134
Salas Eduardo Rene0001209191-22-036375
SEC(opens sec.gov)
Apr 214
Salas Eduardo Rene0001209191-22-025186
SEC(opens sec.gov)

Companies

Address

C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17

RAMSEY, NJ, 07446